Colorectal cancer: clinical trials in Switzerland
21 open trials in Switzerland for colorectal cancer and 16 open trials accepting several types of cancer, according to ClinicalTrials.gov, updated on October 20, 2026.
These results are indicative and do not replace medical advice — discuss them with your doctor.
Open trials
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
NCT06428409RecruitingPhase 1 · Phase 2
In Switzerland: Bellinzona, Geneva
- A Beta-only IL-2 ImmunoTherapY Study
NCT05086692RecruitingPhase 1 · Phase 2
In Switzerland: Zurich
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849RecruitingPhase 3
In Switzerland: Bern, Lausanne, St. Gallen
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483RecruitingPhase 1
In Switzerland: St. Gallen, Winterthur
- Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
NCT07829081Recruiting
In Switzerland: Basel, Biel/Bienne, Lucerne
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192RecruitingPhase 1
In Switzerland: Geneva, Lausanne
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651RecruitingPhase 3
In Switzerland: Schlieren, Zurich
- Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
NCT07617610Recruiting
In Switzerland: Aarau, Baden, Basel, Bern, Biel/Bienne, Chur, Lucerne, St. Gallen, Solothurn, Villars-sur-Glâne, Winterthur, Zurich
- Efficacy and Safety of the CG-100 Intraluminal Bypass Device
NCT04184973Recruiting
In Switzerland: Lausanne
- A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
NCT06567782RecruitingPhase 2
In Switzerland: Bern, Geneva
- Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
NCT06936774RecruitingPhase 3
In Switzerland: Basel, Bern, Lucerne, Winterthur
- Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
NCT06249672Recruiting
In Switzerland: Bern
- The Development of MASLD Among Survivors of Breast or Colorectal Cancer
NCT07280143Recruiting
In Switzerland: Bern
- Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
NCT05748145RecruitingPhase 2
In Switzerland: Bellinzona
- Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Recruiting
In Switzerland: Geneva
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963Recruiting
In Switzerland: Bern, Zurich
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
NCT05502380RecruitingPhase 3
In Switzerland: Zurich
- The DRAGON 2 Trial
NCT05428735Recruiting
In Switzerland: Basel, Winterthur
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT04498767Recruiting
In Switzerland: Bern, Zurich
- Long-term Cohort Study of Mesorectal Excision for Rectal Cancer
NCT05112016Recruiting
In Switzerland: Winterthur
- Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
NCT04109755RecruitingPhase 2
In Switzerland: Geneva
Trials open to several types of cancer
These trials accept several types of cancer, perhaps yours: talk to your doctor about them.
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
NCT07785609RecruitingPhase 2
In Switzerland: Bellinzona, St. Gallen
- A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
NCT07793942Not yet recruitingPhase 2
In Switzerland: Lausanne, St. Gallen
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
NCT05067283RecruitingPhase 1
In Switzerland: Bellinzona, St. Gallen
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908RecruitingPhase 1
In Switzerland: Zurich
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819RecruitingPhase 2
In Switzerland: Bern, Geneva, Zurich
- Safety and Early Signs of Efficacy of IL12-L19L19.
NCT04471987RecruitingPhase 1
In Switzerland: Basel, Bellinzona, Bern, Geneva
- A Nutrition and Exercise Program With Olanzapine Compared to Olanzapine Alone: A Trial in Patients With Advanced Tumors
NCT07722806Not yet recruitingPhase 2
In Switzerland: Winterthur
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
NCT05836324RecruitingPhase 1
In Switzerland: Bellinzona, Lausanne, St. Gallen
- A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
NCT07172919RecruitingPhase 2
In Switzerland: Basel
- A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT05384626RecruitingPhase 1 · Phase 2
In Switzerland: Bellinzona, Lucerne
- A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
NCT06725758RecruitingPhase 1 · Phase 2
In Switzerland: Bellinzona
- First in Human Study of T3P-Y058-739 (T3P)
NCT05120596RecruitingPhase 1 · Phase 2
In Switzerland: Bern, Lausanne, Zurich
- Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766Recruiting
In Switzerland: Bellinzona
- A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485RecruitingPhase 2
In Switzerland: Zurich
- Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
NCT06408688RecruitingPhase 4
In Switzerland: Baden, Basel, Liestal, St. Gallen
- INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042RecruitingPhase 1 · Phase 2
In Switzerland: Zurich